Home | Welcome to Contract Pharma   
Last Updated Saturday, November 29 2014
Print RSS Feed

Breaking News

Gil Roth
December 5, 2013
Biota, CEL-SCI, CPP, Genocea, Immunicum, Lilly, Sanofi, Soligenix  Read More »
December 4, 2013
Gains several anti-infective assets  Read More »
December 4, 2013
To develop DARPin biologics conjugated to toxic agents  Read More »
December 4, 2013
Cain to lead operations, quality, regulatory, and strategic growth  Read More »
December 4, 2013
Will work to identify anti-inflammatory and anti-infective compounds  Read More »
December 4, 2013
FET test is OECD approved  Read More »
December 4, 2013
To provide process development activities Fc-fusion protein  Read More »
December 4, 2013
Aims to provide services from cell line development to cGMP Manufacture   Read More »
December 4, 2013
Doubles dedicated vivarium space  Read More »
Gil Roth
December 4, 2013
ARCA biopharma, Astellas, BioMarin, Immunomedics, Medivation, OncoMed, RXi, Senesco  Read More »
Gil Roth
December 3, 2013
Astellas, Conatus, Durata, Lexicon, Medivation, Sanofi, Synageva  Read More »
December 3, 2013
Expands R&D services after German inspection  Read More »
December 3, 2013
Prepares for commercial launch of BTG’s Varithena  Read More »
December 3, 2013
To supply customized injectable delivery device for Novartis target  Read More »
December 3, 2013
Will provide development services for dendritic cell vaccines  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On